D'Onta Foreman

Running Back

Age: 28
Free Agency: 2024 (UFA)
Accrued Seasons: 6
  • 2024 Salary Cap Charge: $0 (0.00% of cap)
  • 2024 Cash Payout: $0 (0.00% of spending)
  • 2024 Cash to Cap Ratio: 0
  • Contract Value: $2,000,000 ($2,000,000 APY)
  • Fully Guaranteed Money: $1,000,000
  • Contract Ranking: 36/160 at RB

Current Contract

(UFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202327$1,525,000$375,000$100,000$625,000$2,000,0000.9%
Total$1,525,000$375,000$100,000$625,000$2,000,000

Contract Notes

D'onta Foreman signed a one year contract with the Carolina Panthers worth $2 million with $940,000 guaranteed.

Cash Flows

- fully earned money
- unearned or partially earned money
$2M
2023
Cash Due$2,000,000
Running Cash$2,000,000
Career Earnings: $7,594,207
Career APY: $1,265,701
Potential Earnings: $6,974,095
Total Guarantees: $3,458,968
Largest Cash Payment: $2,000,000 (2022)
Largest Cap Number: $2,000,000 (2022)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
ColtsDraftedTerminated20174$3,259,984$814,996$759,484$00.0%$0
TexansDraftedTerminated20174$3,259,984$814,996$759,484$1,771,69054.3%$885,845
TitansPracticeTerminated20201$204,000$204,000$0$00.0%$0
TitansPracticeExpired20201$209,529$209,529$0$209,529100.0%$209,529
TitansSFAExpired20201$750,000$750,000$0$481,76564.2%$481,765
FalconsSFATerminated20211$920,000$920,000$0$00.0%$0
FalconsPracticeTerminated20211$252,000$252,000$0$00.0%$0
TitansPracticeTerminated20211$252,000$252,000$0$00.0%$0
TitansSFAExpired20211$920,000$920,000$0$511,11155.6%$511,111
PanthersUFAExpired20221$2,000,000$2,000,000$940,000$2,000,000100.0%$2,000,000
BearsUFAActive20231$2,000,000$2,000,000$1,000,000$2,000,000100.0%$2,000,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Colts0$518,583$0$00.0%$518,8530.0%
Texans2$1,771,690$885,845$1,391,9480.0%$379,7420.0%
Titans3$1,303,934$434,645$1,117,6990.0%$101,5290.0%
Falcons0$0$0$00.0%$00.0%
Panthers1$2,000,000$2,000,000$2,000,0000.0%$00.0%
Bears1$2,000,000$2,000,000$2,000,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2017Texans$465,000$189,871$0$0$613,5770.4%$1,183,190
2018Texans$588,500$189,871$0$0$778,3710.4%$588,500
2020Titans$750,000$0$0$0$397,0590.2%$481,765
2021Titans$920,000$0$0$0$511,1110.3%$511,111
2022Panthers$1,035,000$940,000$25,000$0$2,000,0000.9%$2,000,000
2023Bears$1,525,000$375,000$100,000$625,000$2,000,0000.9%$2,000,000
Total$5,493,029$1,694,742$125,000$625,000$6,509,647$6,974,095
Dead Money History
TeamYearCap ChargeCash Paid
Texans2019$189,871$0
Colts2019$518,853$518,583
Texans2020$189,871$0
Titans2020$101,529$101,529
Total$1,000,124$620,112

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2017106013.3%1.0%783274.2268313.8021
201811232.8%0.0%7-1-0.1022814.0110
20206042.7%2.9%22954.30155.0100
202190019.4%0.0%1335664.33912313.7000
2022170034.7%0.0%2039144.555265.2000
202391723.6%0.0%1094253.9411777.0100

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$1,406,000$2,000,000
Injury Adjusted$1,705,194$1,875,000
test
OTC Valuation $2.7M $5.4M $8M $10.7M $13.4M APY $2.7M $5.3M $8M $10.7M $13.3M $7,072,000 $4,215,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.